Market Cap 495.69M
Revenue (ttm) 0.00
Net Income (ttm) -167.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,591,789
Avg Vol 4,742,482
Day's Range N/A - N/A
Shares Out 163.06M
Stochastic %K 64%
Beta 3.21
Analysts Strong Sell
Price Target $13.38

Company Profile

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, systemic lupus erythe...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 759 3100
Address:
2929 Arch Street, Suite 600, Philadelphia, United States
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 6:17 PM
$CABA From 3.10 to 3.13, a large drainage area 🙄
0 · Reply
albertopastor1
albertopastor1 Jun. 29 at 5:30 PM
$CABA just a little more than 2 months till the warrants expire. The big conferences are now behind us . Might be that the sell off is due to warrants being exercised?
1 · Reply
Correo
Correo Jun. 29 at 4:52 PM
$CABA With the new reconstitution published today, $CABA will remain in the Russell 3000. Furthermore, it has moved from the Nasdaq Capital Market to the Nasdaq Global Select Market—Nasdaq’s most demanding tier regarding financial and liquidity requirements. This should be viewed as a positive signal from a market perspective. Many index funds had to sell their shares and restructure their portfolios upon learning that $CABA would be dropping out of the Russell 2500. In my opinion, this was the reason for the downward pressure on the stock; the trend should shift from here on out. Good luck.
0 · Reply
Moonman321
Moonman321 Jun. 29 at 4:07 PM
$CABA $LLY this is the end of the line for you abdul lol
0 · Reply
Moonman321
Moonman321 Jun. 29 at 3:57 PM
$CABA this will be a good week 🐻 🩸 
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 3:07 PM
$CABA Repeating the behavior time after time
1 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 2:54 PM
$CABA $LLY bunk
1 · Reply
Swami747
Swami747 Jun. 29 at 2:21 PM
$CABA $LLY will support the share price until the next catalyst, which will catapult it to the $6 range.
1 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 2:13 PM
$CABA 😅😅The behavior has become clear and understandable, but there are those who do not want to understand it.
0 · Reply
Bronco6970
Bronco6970 Jun. 29 at 1:57 PM
$CABA it’s called, stealing your shares right before liftoff 🚀
1 · Reply
Latest News on CABA
Cabaletta Bio Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 26 days ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 4 weeks ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio presents new clinical data for rese-cel

2026-05-14T14:21:15.000Z - 6 weeks ago

Cabaletta Bio presents new clinical data for rese-cel


Cabaletta Bio reports Q1 EPS (39c), consensus (39c)

2026-05-14T12:08:57.000Z - 6 weeks ago

Cabaletta Bio reports Q1 EPS (39c), consensus (39c)


Cabaletta Bio Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 6 weeks ago

Cabaletta Bio Quarterly report: Q1 2026


Cabaletta Bio Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 6 weeks ago

Cabaletta Bio Earnings release: Q1 2026


Cabaletta Bio Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 6 weeks ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio, Cellares enter 10-year commercial agreement

2026-04-28T12:38:26.000Z - 2 months ago

Cabaletta Bio, Cellares enter 10-year commercial agreement


Cabaletta Bio Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio Slides: Corporate presentation

Apr 20, 2026, 7:00 AM EDT - 2 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Cabaletta Bio Proxy statement: Proxy filing


Cabaletta Bio price target raised to $16 from $15 at Guggenheim

2026-03-23T18:00:24.000Z - 3 months ago

Cabaletta Bio price target raised to $16 from $15 at Guggenheim


Cabaletta Bio reports Q4 EPS (40c), consensus (47c)

2026-03-23T11:40:46.000Z - 3 months ago

Cabaletta Bio reports Q4 EPS (40c), consensus (47c)


Cabaletta Bio Annual report: Q4 2025

Mar 23, 2026, 7:30 AM EDT - 3 months ago

Cabaletta Bio Annual report: Q4 2025


Cabaletta Bio Earnings release: Q4 2025

Mar 23, 2026, 7:30 AM EDT - 3 months ago

Cabaletta Bio Earnings release: Q4 2025


Cabaletta Bio Slides: Corporate presentation

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio announces 2026 strategic priorities

2026-01-12T13:38:11.000Z - 6 months ago

Cabaletta Bio announces 2026 strategic priorities


Cabaletta Bio Announces 2026 Strategic Priorities

Jan 12, 2026, 8:00 AM EST - 6 months ago

Cabaletta Bio Announces 2026 Strategic Priorities


Cabaletta Bio Slides: Corporate presentation

Jan 11, 2026, 7:00 AM EST - 6 months ago

Cabaletta Bio Slides: Corporate presentation


Cabaletta Bio Slides: Corporate Presentation

Dec 5, 2025, 7:00 AM EST - 7 months ago

Cabaletta Bio Slides: Corporate Presentation


Cabaletta Bio reports Q3 EPS (44c), consensus (46c)

2025-11-10T12:38:12.000Z - 8 months ago

Cabaletta Bio reports Q3 EPS (44c), consensus (46c)


Cabaletta Bio sees cash runway into 2H26

2025-11-10T12:37:22.000Z - 8 months ago

Cabaletta Bio sees cash runway into 2H26


Cabaletta Bio Quarterly report: Q3 2025

Nov 10, 2025, 7:30 AM EST - 8 months ago

Cabaletta Bio Quarterly report: Q3 2025


Cabaletta Bio Earnings release: Q3 2025

Nov 10, 2025, 7:30 AM EST - 8 months ago

Cabaletta Bio Earnings release: Q3 2025


Cabaletta Bio Registration statement: Registration Filing

Aug 7, 2025, 8:00 AM EDT - 11 months ago

Cabaletta Bio Registration statement: Registration Filing


Cabaletta Bio Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 11 months ago

Cabaletta Bio Quarterly report: Q2 2025


Cabaletta Bio Earnings release: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 11 months ago

Cabaletta Bio Earnings release: Q2 2025


Cabaletta Bio Slides: Investor Presentation

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Slides: Investor Presentation


Cabaletta Bio Quarterly report: Q1 2025

May 15, 2025, 9:30 AM EDT - 1 year ago

Cabaletta Bio Quarterly report: Q1 2025


Cabaletta Bio Proxy statement: Proxy Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Earnings release: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Earnings release: Q4 2024


Cabaletta Bio Annual report: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Cabaletta Bio Annual report: Q4 2024


Cabaletta Bio Transcript: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Transcript: Status Update


Cabaletta Bio Press release: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Press release: Status Update


Cabaletta Bio Slides: Status Update

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cabaletta Bio Slides: Status Update


Cabaletta Bio Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Cabaletta Bio Quarterly report: Q3 2024


Cabaletta Bio Earnings release: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Cabaletta Bio Earnings release: Q3 2024


Cabaletta Bio Quarterly report: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cabaletta Bio Quarterly report: Q2 2024


Cabaletta Bio Earnings release: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q2 2024


Cabaletta Bio Transcript: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Transcript: Study Update


Cabaletta Bio Press release: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Press release: Study Update


Cabaletta Bio Slides: Study Update

Jun 14, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Slides: Study Update


Cabaletta Bio Quarterly report: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Quarterly report: Q1 2024


Cabaletta Bio Earnings release: Q1 2024

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q1 2024


Cabaletta Bio Slides: Corporate Presentation

May 15, 2024, 7:00 AM EDT - 2 years ago

Cabaletta Bio Slides: Corporate Presentation


Cabaletta Bio Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Proxy statement: Proxy Filing


Cabaletta Bio Earnings release: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Earnings release: Q4 2023


Cabaletta Bio Annual report: Q4 2023

Mar 21, 2024, 8:00 AM EDT - 2 years ago

Cabaletta Bio Annual report: Q4 2023


Cabaletta Bio Slides: FY 2024

Jan 9, 2024, 8:15 PM EST - 2 years ago

Cabaletta Bio Slides: FY 2024


Cabaletta Bio Quarterly report: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Cabaletta Bio Quarterly report: Q3 2023


Cabaletta Bio Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 2 years ago

Cabaletta Bio Earnings release: Q3 2023


Cabaletta Bio Quarterly report: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Cabaletta Bio Quarterly report: Q2 2023


Cabaletta Bio Earnings release: Q2 2023

Aug 10, 2023, 7:00 AM EDT - 3 years ago

Cabaletta Bio Earnings release: Q2 2023


ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 6:17 PM
$CABA From 3.10 to 3.13, a large drainage area 🙄
0 · Reply
albertopastor1
albertopastor1 Jun. 29 at 5:30 PM
$CABA just a little more than 2 months till the warrants expire. The big conferences are now behind us . Might be that the sell off is due to warrants being exercised?
1 · Reply
Correo
Correo Jun. 29 at 4:52 PM
$CABA With the new reconstitution published today, $CABA will remain in the Russell 3000. Furthermore, it has moved from the Nasdaq Capital Market to the Nasdaq Global Select Market—Nasdaq’s most demanding tier regarding financial and liquidity requirements. This should be viewed as a positive signal from a market perspective. Many index funds had to sell their shares and restructure their portfolios upon learning that $CABA would be dropping out of the Russell 2500. In my opinion, this was the reason for the downward pressure on the stock; the trend should shift from here on out. Good luck.
0 · Reply
Moonman321
Moonman321 Jun. 29 at 4:07 PM
$CABA $LLY this is the end of the line for you abdul lol
0 · Reply
Moonman321
Moonman321 Jun. 29 at 3:57 PM
$CABA this will be a good week 🐻 🩸 
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 3:07 PM
$CABA Repeating the behavior time after time
1 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 2:54 PM
$CABA $LLY bunk
1 · Reply
Swami747
Swami747 Jun. 29 at 2:21 PM
$CABA $LLY will support the share price until the next catalyst, which will catapult it to the $6 range.
1 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 2:13 PM
$CABA 😅😅The behavior has become clear and understandable, but there are those who do not want to understand it.
0 · Reply
Bronco6970
Bronco6970 Jun. 29 at 1:57 PM
$CABA it’s called, stealing your shares right before liftoff 🚀
1 · Reply
Daniel_Ocean
Daniel_Ocean Jun. 29 at 1:45 PM
$CABA I like it. I like it a lot
0 · Reply
Moonman321
Moonman321 Jun. 29 at 1:43 PM
$CABA shorts are going to get wrecked 
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 29 at 1:42 PM
$CABA Uuuuuuuuuuuuuuppppp, then down 🙄
0 · Reply
Viktor4o
Viktor4o Jun. 28 at 8:53 PM
$CABA Price prediction for tomorrow?
2 · Reply
pleasemoney
pleasemoney Jun. 28 at 6:13 PM
$CABA not only russell but we also got added to S&P Biotechnology Select Industry Index (XBI tracks it) https://www.marketscreener.com/news/cabaletta-bio-inc-nasdaqgs-caba-added-to-s-p-biotechnology-select-industry-index-ce7f5cd3d88df423
2 · Reply
WastedTrader
WastedTrader Jun. 27 at 3:21 AM
$CABA do you really want to bet against this 😂 new floor solid🚀🚀🚀
1 · Reply
WastedTrader
WastedTrader Jun. 27 at 2:33 AM
$CABA follow the volume caba brothers 🚀 short interest is growing, the floor is being rebuilt at 3$. One spark of news and buying pressure and were going to start knocking on the price targets set by analysts real quick
1 · Reply
pleasemoney
pleasemoney Jun. 27 at 2:02 AM
$CABA thanks russell, hold us close and never let go🥰
1 · Reply
Viktor4o
Viktor4o Jun. 26 at 8:05 PM
$CABA Is Strong 💪💪💪
0 · Reply
Jarvis7424
Jarvis7424 Jun. 26 at 8:02 PM
$CABA another week pinned at $3
2 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 Jun. 26 at 5:06 PM
$CABA I haven't posted any comments today about Caba stock. Has its price increased? Because I see some people saying that I'm the reason for its decline.
4 · Reply
Achandler787
Achandler787 Jun. 26 at 3:58 PM
$CABA bought another 30k 👍 This stock added to the Russel and the news gradient looks fantastic for the rest of the year to me!
2 · Reply